ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,225Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 43

$1.06M Total Retail Price of All Prescriptions

Rank: 1 out of 43

602 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ZOLPIDEM TARTRATE 369 280 1 33
SIMVASTATIN 357 245 2 1
AMLODIPINE BESYLATE 319 244 3 6
CRESTOR 312 267 4 26
NEXIUM 295 223 5 29
LEVOTHYROXINE SODIUM 282 217 6 2
OMEPRAZOLE 252 151 7 7
TAMSULOSIN HCL 221 147 8 28
SINGULAIR 217 121 9 68
FUROSEMIDE 206 186 10 4
METFORMIN HCL 193 140 11 10
METOPROLOL SUCCINATE 190 169 12 13
RANEXA 185 185 13 131
JANUMET 180 135 14 96
BENICAR HCT 172 129 15 137
LOSARTAN POTASSIUM 169 119 16 25
ATORVASTATIN CALCIUM 166 129 17 12
METOPROLOL TARTRATE 163 108 18 5
HYDROCHLOROTHIAZIDE 162 130 19 9
CLOPIDOGREL 161 135 20 34
DIOVAN HCT 157 95 21 117
BYSTOLIC 157 123 21 143
PLAVIX 148 128 23 55
SPIRIVA 131 63 24 46
AZITHROMYCIN 125 96 25 64
MIRTAZAPINE 122 110 26 15
WARFARIN SODIUM 121 108 27 8
MELOXICAM 116 92 28 64
JANUVIA 103 78 29 41
ALENDRONATE SODIUM 103 93 29 24
MONTELUKAST SODIUM 102 52 31 109
VOLTAREN 102 79 31 171
BETAMETHASONE DIPROPIONATE 95 73 33 173
VENTOLIN HFA 92 14 34 63
PROAIR HFA 89 41 35 52
GLIMEPIRIDE 89 72 35 177
LOVAZA 88 83 37 78
PANTOPRAZOLE SODIUM 86 70 38 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 63 38 79
BENICAR 86 75 38 180
RAMIPRIL 80 64 41 60
SAVELLA 77 58 42 191
ALLOPURINOL 73 66 43 66
ISOSORBIDE MONONITRATE ER 72 70 44 42
LISINOPRIL 71 23 45 3
ESCITALOPRAM OXALATE 71 59 45 85
LACTULOSE 70 58 47 88
RAPAFLO 69 54 48 201
DEXILANT 67 59 49 204
LEVEMIR FLEXPEN 66 62 50 208
DIOVAN 65 64 51 38
CARVEDILOL 65 51 51 23
FENOFIBRATE 64 42 53 148
EFFIENT 62 41 54 217
SERTRALINE HCL 62 52 54 20
GABAPENTIN 59 51 56 16
LOSARTAN-HYDROCHLOROTHIAZIDE 58 49 57 115
PREDNISONE 55 40 58 32
LEVOFLOXACIN 54 35 59 100
CLONIDINE HCL 53 26 60 86
RANITIDINE HCL 51 51 61 21
AMLODIPINE BESYLATE-BENAZEPRIL 51 32 61 77
AVODART 50 22 63 252
LIPITOR 50 35 63 252
PEN NEEDLE 50 34 63 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.